About this trial
The integration of Artificial Intelligence (AI) in anesthesiology offers the potential to shift patient monitoring from reactive to predictive. Deep learning architectures, specifically Long Short-Term Memory (LSTM) networks, excel at processing complex, time-series data to forecast future clinical states.
While standard PK/PD models (such as the state of the art Eleveld model for Propofol and Remifentanil) estimate target-site drug concentrations (Ce), they do not account for real-time, patient-specific dynamic responses. This study aims to deploy an AI framework designed to predict future physiological states.
Eligibility criteria
Qualifiers
Patients scheduled for elective surgery requiring general anesthesia.
Procedures requiring continuous depth of anesthesia monitoring (BIS).
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Universitair Ziekenhuis Brussel
Lead sponsor
AZ Sint-Jan AV
Collaborator